332 related articles for article (PubMed ID: 19929741)
1. A cluster of amyotrophic lateral sclerosis in New Hampshire: a possible role for toxic cyanobacteria blooms.
Caller TA; Doolin JW; Haney JF; Murby AJ; West KG; Farrar HE; Ball A; Harris BT; Stommel EW
Amyotroph Lateral Scler; 2009; 10 Suppl 2():101-8. PubMed ID: 19929741
[TBL] [Abstract][Full Text] [Related]
2. Cyanobacteria and BMAA exposure from desert dust: a possible link to sporadic ALS among Gulf War veterans.
Cox PA; Richer R; Metcalf JS; Banack SA; Codd GA; Bradley WG
Amyotroph Lateral Scler; 2009; 10 Suppl 2():109-17. PubMed ID: 19929742
[TBL] [Abstract][Full Text] [Related]
3. Beyond Guam: the cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases.
Bradley WG; Mash DC
Amyotroph Lateral Scler; 2009; 10 Suppl 2():7-20. PubMed ID: 19929726
[TBL] [Abstract][Full Text] [Related]
4. Detection of cyanotoxins, β-N-methylamino-L-alanine and microcystins, from a lake surrounded by cases of amyotrophic lateral sclerosis.
Banack SA; Caller T; Henegan P; Haney J; Murby A; Metcalf JS; Powell J; Cox PA; Stommel E
Toxins (Basel); 2015 Jan; 7(2):322-36. PubMed ID: 25643180
[TBL] [Abstract][Full Text] [Related]
5. Cyanobacteria, neurotoxins and water resources: are there implications for human neurodegenerative disease?
Metcalf JS; Codd GA
Amyotroph Lateral Scler; 2009; 10 Suppl 2():74-8. PubMed ID: 19929737
[TBL] [Abstract][Full Text] [Related]
6. Cyanobacterial neurotoxin BMAA in ALS and Alzheimer's disease.
Pablo J; Banack SA; Cox PA; Johnson TE; Papapetropoulos S; Bradley WG; Buck A; Mash DC
Acta Neurol Scand; 2009 Oct; 120(4):216-25. PubMed ID: 19254284
[TBL] [Abstract][Full Text] [Related]
7. Possible therapy for ALS based on the cyanobacteria/BMAA hypothesis.
Bradley WG
Amyotroph Lateral Scler; 2009; 10 Suppl 2():118-23. PubMed ID: 19929743
[TBL] [Abstract][Full Text] [Related]
8. Detection of cyanobacterial neurotoxin β-N-methylamino-l-alanine within shellfish in the diet of an ALS patient in Florida.
Banack SA; Metcalf JS; Bradley WG; Cox PA
Toxicon; 2014 Nov; 90():167-73. PubMed ID: 25123936
[TBL] [Abstract][Full Text] [Related]
9. Linking β-methylamino-L-alanine exposure to sporadic amyotrophic lateral sclerosis in Annapolis, MD.
Field NC; Metcalf JS; Caller TA; Banack SA; Cox PA; Stommel EW
Toxicon; 2013 Aug; 70():179-83. PubMed ID: 23660330
[TBL] [Abstract][Full Text] [Related]
10. Spatial clustering of amyotrophic lateral sclerosis and the potential role of BMAA.
Caller TA; Field NC; Chipman JW; Shi X; Harris BT; Stommel EW
Amyotroph Lateral Scler; 2012 Jan; 13(1):25-32. PubMed ID: 22214351
[TBL] [Abstract][Full Text] [Related]
11. Sporadic amyotrophic lateral sclerosis as an infectious disease: a possible role of cyanobacteria?
Stipa G; Taiuti R; de Scisciolo G; Arnetoli G; Tredici MR; Biondi N; Barsanti L; Lolli F
Med Hypotheses; 2006; 67(6):1363-71. PubMed ID: 16890380
[TBL] [Abstract][Full Text] [Related]
12. Distinguishing the cyanobacterial neurotoxin beta-N-methylamino-L-alanine (BMAA) from its structural isomer 2,4-diaminobutyric acid (2,4-DAB).
Banack SA; Downing TG; Spácil Z; Purdie EL; Metcalf JS; Downing S; Esterhuizen M; Codd GA; Cox PA
Toxicon; 2010 Nov; 56(6):868-79. PubMed ID: 20561540
[TBL] [Abstract][Full Text] [Related]
13. Aerosolization of cyanobacteria as a risk factor for amyotrophic lateral sclerosis.
Stommel EW; Field NC; Caller TA
Med Hypotheses; 2013 Feb; 80(2):142-5. PubMed ID: 23246360
[TBL] [Abstract][Full Text] [Related]
14. Occurrence of beta-methylamino-l-alanine (BMAA) in ALS/PDC patients from Guam.
Murch SJ; Cox PA; Banack SA; Steele JC; Sacks OW
Acta Neurol Scand; 2004 Oct; 110(4):267-9. PubMed ID: 15355492
[TBL] [Abstract][Full Text] [Related]
15. Detection of the neurotoxin BMAA within cyanobacteria isolated from freshwater in China.
Li A; Tian Z; Li J; Yu R; Banack SA; Wang Z
Toxicon; 2010 May; 55(5):947-53. PubMed ID: 19822166
[TBL] [Abstract][Full Text] [Related]
16. Determination of the neurotoxins BMAA (beta-N-methylamino-L-alanine) and DAB (alpha-,gamma-diaminobutyric acid) by LC-MSMS in Dutch urban waters with cyanobacterial blooms.
Faassen EJ; Gillissen F; Zweers HA; Lürling M
Amyotroph Lateral Scler; 2009; 10 Suppl 2():79-84. PubMed ID: 19929738
[TBL] [Abstract][Full Text] [Related]
17. Return of the cycad hypothesis - does the amyotrophic lateral sclerosis/parkinsonism dementia complex (ALS/PDC) of Guam have new implications for global health?
Ince PG; Codd GA
Neuropathol Appl Neurobiol; 2005 Aug; 31(4):345-53. PubMed ID: 16008818
[TBL] [Abstract][Full Text] [Related]
18. Detection of the suspected neurotoxin β-methylamino-l-alanine (BMAA) in cyanobacterial blooms from multiple water bodies in Eastern Australia.
Main BJ; Bowling LC; Padula MP; Bishop DP; Mitrovic SM; Guillemin GJ; Rodgers KJ
Harmful Algae; 2018 Apr; 74():10-18. PubMed ID: 29724339
[TBL] [Abstract][Full Text] [Related]
19. Is there a role for naturally occurring cyanobacterial toxins in neurodegeneration? The beta-N-methylamino-L-alanine (BMAA) paradigm.
Papapetropoulos S
Neurochem Int; 2007 Jun; 50(7-8):998-1003. PubMed ID: 17296249
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of β-methylamino-L-alanine (BMAA) and its isomers in freshwater cyanobacteria isolated from eastern Australia.
Violi JP; Mitrovic SM; Colville A; Main BJ; Rodgers KJ
Ecotoxicol Environ Saf; 2019 May; 172():72-81. PubMed ID: 30682636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
